Publication: Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling
Issued Date
2020-05-03
Resource Type
ISSN
1532432X
03630269
03630269
Other identifier(s)
2-s2.0-85087180198
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Hemoglobin. Vol.44, No.3 (2020), 184-189
Suggested Citation
Uday Y.H. Abdullah, Hishamshah M. Ibrahim, Noraesah Binti Mahmud, Mohamad Zaki Salleh, Lay Kek Teh, Mohd Nur Fakhruzzaman bin Noorizhab, Bin Alwi Zilfalil, Haitham Muhammed Jassim, Prapin Wilairat, Suthat Fucharoen Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling. Hemoglobin. Vol.44, No.3 (2020), 184-189. doi:10.1080/03630269.2020.1781652 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/57735
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling
Abstract
© 2020 Informa UK Limited, trading as Taylor & Francis Group. Effective prevention of β-thalassemia (β-thal) requires strategies to detect at-risk couples. This is the first study attempting to assess the prevalence of silent β-thal carriers in the Malaysian population. Hematological and clinical parameters were evaluated in healthy blood donors and patients with β-thal trait, Hb E (HBB: c.79G>A)/β-thal and β-thal major (β-TM). β-Globin gene sequencing was carried out for 52 healthy blood donors, 48 patients with Hb E/β-thal, 34 patients with β-TM and 38 patients with β-thal trait. The prevalence of silent β-thal carrier phenotypes found in 25.0% of healthy Malaysian blood donors indicates the need for clinician’s awareness of this type in evaluating β-thal in Malaysia. Patients with β-TM present at a significantly younger age at initial diagnosis and require more blood transfusions compared to those with Hb E/β-thal. The time at which genomic DNA was extracted after blood collection, particularly from patients with β-TM and Hb E/β-thal, was found to be an important determinant of the quality of the results of the β-globin sequencing. Public education and communication campaigns are recommended as apparently healthy individuals have few or no symptoms and normal or borderline hematological parameters. β-Globin gene mutation characterization and screening for silent β-thal carriers in regions prevalent with β-thal are recommended to develop more effective genetic counseling and management of β-thal.